US EditionAlzheimer's blood test could 'revolutionise' diagnosis
The ADAPT trial will recruit 1,100 patients from 20 NHS memory clinics to evaluate if a £100 blood test improves Alzheimer's diagnosis accuracy from 70% to over 90%.
- A national trial by University College London is recruiting 1,100 people from 20 NHS memory clinics to test a new blood test for early signs of Alzheimer's disease.
- The trial is part of the £10 million Blood Biomarker Challenge project, supported by the People's Postcode Lottery, aiming for routine dementia screening.
- Professor Jonathan Schott is leading the ADAPT trial, which aims to improve Alzheimer's diagnosis accuracy from 70% to 90% by combining a blood test with clinical assessments.
- Professor Fiona Carragher highlighted that late dementia diagnoses often limit access to support and treatment.
41 Articles
41 Articles
A clinical trial in the UK will be launched to evaluate the effectiveness of blood tests to improve and accelerate the diagnosis of Alzheimer's disease.
UK patients to trial blood test that could 'revolutionise' Alzheimer's diagnosis
A study will investigate if a blood test, which is accurate at detecting proteins linked to Alzheimer's, can help improve diagnosis and treatment plans for patients showing early signs of the deadly disease, the most common cause of dementia.
UK launches groundbreaking trial of £100 blood test that could revolutionise Alzheimer's diagnosis
Medical professionals across Britain have begun enrolling participants in a groundbreaking clinical study examining whether a £100 blood test could revolutionise how Alzheimer's disease is identified within the NHS.The research initiative will involve more than 1,000 individuals experiencing potential dementia symptoms, drawn from specialist memory centres throughout the United Kingdom.Researchers hope the examination, which analyses levels of a…
Coverage Details
Bias Distribution
- 53% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
